References
- Abraham E. 2003. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis. 187:364–369. doi:https://doi.org/10.1086/374750
- Aebi HE. 1983. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Academic Press: London, UK; p. 673–684.
- Aleksa K, Halachmi N, Ito S, Koren G. 2005. A tubule cell model for ifosfamide nephrotoxicity. Can J Physiol Pharm. 83:499–508. doi:https://doi.org/10.1139/y05-036
- Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y. 2001. Endothelial apoptosis induced by oxidative stress through activation of NF-κB: anti-apoptotic effect of antioxidant agents on endothelial cells. Hypertension. 38:48–55. doi:https://doi.org/10.1161/01.HYP.38.1.48
- Appierto V, Villani MG, Cavadini E, Lotan R, Vinson C, Formelli F. 2004. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. Cell Death Differ. 11:270–279. doi:https://doi.org/10.1038/sj.cdd.4401349.
- Arslan H, Altun S, Özdemir S. 2017. Acute toxication of deltamethrin results in activation of iNOS, 8-OHdG and up-regulation of caspase 3, iNOS gene expression in common carp (Cyprinus carpio L.). Aquat Toxicol. 187:90–99. doi:https://doi.org/10.1016/j.aquatox.2017.03.014
- Badary OA. 1998. Taurine attenuates Fanconi syndrome induced by ifosfamide without compromising its antitumor activity. Oncol Res. 10:355–360.
- Badary OA. 1999. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol. 67:135–142. doi:https://doi.org/10.1016/S0378-8741(98)00242-6
- Benzer F, Kandemir FM, Ozkaraca M, Kucukler S, Caglayan C. 2018. Curcumin ameliorates doxorubicin‐induced cardiotoxicity by abrogation of inflammation, apoptosis, oxidative DNA damage, and protein oxidation in rats. J Biochem Mol Toxicol. 32:e22030. doi:https://doi.org/10.1002/jbt.22030
- Bonventre JV. 2014. Kidney injury molecule-1: a translational journey. Trans Am Clin Clim Assoc. 125:293–299.
- Buyuklu M, Kandemir FM, Ozkaraca M, Set T, Bakirci EM, Topal E. 2014. Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis. Eur Rev Med Pharm Sci. 18:461–470.
- Caglayan C, Kandemir FM, Yildirim S, Kucukler S, Eser G, Biology. 2019. Rutin protects mercuric chloride‐induced nephrotoxicity via targeting of aquaporin 1 level, oxidative stress, apoptosis and inflammation in rats. J Trace Elem Med Biol. 54:69–78. doi:https://doi.org/10.1016/j.jtemb.2019.04.007
- Cai B, Gan X, He J, He W, Qiao Z, Ma B, Han Y. 2018. Morin attenuates cigarette smoke-induced lung inflammation through inhibition of PI3K/AKT/NF-κB signaling pathway. Int Immunopharmacol. 63:198–203. doi:https://doi.org/10.1016/j.intimp.2018.07.035
- Chen N, Aleksa K, Woodland C, Rieder M, Koren G. 2007. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells. Transl Res. 150:51–57. doi:https://doi.org/10.1016/j.trsl.2007.02.001
- Chen N, Aleksa K, Woodland C, Rieder M, Koren G. 2008. N‐acetylcysteine prevents ifosfamide‐induced nephrotoxicity in rats. Br J Pharmacol. 153:1364–1372. doi:https://doi.org/10.1038/bjp.2008.15
- Comakli S, Özdemir S. 2019. Comparative evaluation of the immune responses in cattle mammary tissues naturally infected with bovine parainfluenza virus type 3 and bovine alpha-herpes virus-1. Pathogens. 8:26–38. doi:https://doi.org/10.3390/pathogens8010026
- Dechant KL, Brogden RN, Pilkington T, Faulds D. 1991. Ifosfamide/mesna. Drugs. 42:428–467. doi:https://doi.org/10.2165/00003495-199142030-00006.
- Deiana M, Incani A, Rosa A, Corona G, Atzeri A, Loru D, Melis MP, Dessì MA. 2008. Protective effect of hydroxytyrosol and its metabolite homovanillic alcohol on H2O2 induced lipid peroxidation in renal tubular epithelial cells. Food Chem Toxicol. 46:2984–2990. doi:https://doi.org/10.1016/j.fct.2008.05.037
- Elias AD, Eder J, Shea T, Begg C, Frei E 3rd, Antman K. 1990. High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol. 8:170–178. doi:https://doi.org/10.1200/JCO.1990.8.1.170
- Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M. 1999. The C-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol Cell Biol. 19:2594–2600. doi:https://doi.org/10.1128/MCB.19.4.2594
- Erster S, Moll UM. 2005. Stress-induced p53 runs a transcription-independent death program. Biochem Biophys Res Commun. 331:843–850. doi:https://doi.org/10.1016/j.bbrc.2005.03.187
- Fisher-Wellman K, Bell HK, Bloomer RJ. 2009. Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxid Med Cell Longev. 2:43–51. doi:https://doi.org/10.4161/oxim.2.1.7732.
- Foo SY, Nolan GP. 1999. NF-κB to the rescue: rELs, apoptosis and cellular transformation. Trends Genet. 15:229–235. doi:https://doi.org/10.1016/S0168-9525(99)01719-9
- Ginis Z, Ozturk G, Albayrak A, Kurt SN, Albayrak M, Fadillioglu E. 2016. Protective effects of caffeic acid phenethyl ester on ifosfamide-induced central neurotoxicity in rats. Toxicol Ind Health. 32:337–343. doi:https://doi.org/10.1177/0748233713500817
- Gocer H, Topal F, Topal M, Küçük M, Teke D, Gülçin İ, Alwasel SH, Supuran CT. 2016. Acetylcholinesterase and carbonic anhydrase isoenzymes I and II inhibition profiles of taxifolin. J Enz Inhib Med Chem. 31:441–447. doi:https://doi.org/10.3109/14756366.2015.1036051
- Gómez-Fernández JC. 2014. Functions of the C-terminal domains of apoptosis-related proteins of the Bcl-2 family. Chem Phys Lipids. 183:77–90. doi:https://doi.org/10.1016/j.chemphyslip.2014.05.003.
- Gulcin İ. 2020. Antioxidants and antioxidant methods: an updated overview. Arch Toxicol. 94:1–65. doi:https://doi.org/10.1007/s00204-020-02689-3
- Gülcin İ. 2012. Antioxidant activity of food constituents: an overview. Arch Toxicol. 86:345–391. doi:https://doi.org/10.1007/s00204-011-0774-2
- Hanly L, Chen N, Rieder M, Koren G. 2009. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. Exp Opin Drug Safe. 8:155–168. doi:https://doi.org/10.1517/14740330902808169.
- Hemann M, Lowe S. 2006. The p53–Bcl-2 connection. Cell Death Differ. 13:1256–1259. doi:https://doi.org/10.1038/sj.cdd.4401962
- Hollander MC, Fornace AJ. 1989. Induction of fos RNA by DNA-damaging agents. Cancer Res. 49:1687–1692.
- Kalra N, Kumar V. 2004. C-fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J Biol Chem. 279:25313–25319. doi:https://doi.org/10.1074/jbc.M400932200
- Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Mahamadu A, Dortbudak MB. 2018. Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney. Biomed Pharmacother. 105:981–991. doi:https://doi.org/10.1016/j.biopha.2018.06.048
- Kapoor R, Kakkar P. 2012. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS One. 7:e41663. doi:https://doi.org/10.1371/journal.pone.0041663
- Kim SY, Moon A. 2012. Drug-induced nephrotoxicity and its biomarkers. Biomol Ther. 20:268–272. doi:https://doi.org/10.4062/biomolther.2012.20.3.268
- Kuzu M, Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Turk E. 2018. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmacother. 106:443–453. doi:https://doi.org/10.1016/j.biopha.2018.06.161
- Kuzu M, Yıldırım S, Kandemir FM, Küçükler S, Çağlayan C, Türk E, Dörtbudak MB. 2019. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats. Chem Biol Interact. 308:89–100. doi:https://doi.org/10.1016/j.cbi.2019.05.017
- Liu X, Huang Z, Zou X, Yang Y, Qiu Y, Wen Y. 2014. Panax notoginseng saponins attenuates cisplatin-induced nephrotoxicity via inhibiting the mitochondrial pathway of apoptosis. Int J Clin Exp Pathol. 7:8391–8400.
- Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 25:402–408. doi:https://doi.org/10.1006/meth.2001.1262
- Loebstein R, Koren G. 1998. Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics. 101:e8. doi:https://doi.org/10.1542/peds.101.6.e8
- Lohr JW, Willsky GR, Acara MA. 1998. Renal drug metabolism. Pharmacol Rev. 50:107–142.
- Lowry O, Rosebrough N, Farr A, Randall R. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275. doi:https://doi.org/10.1016/S0021-9258(19)52451-6.
- Lu QB, Du Q, Wang HP, Tang ZH, Wang YB, Sun HJ. 2020. Salusin-β mediates tubular cell apoptosis in acute kidney injury: involvement of the PKC/ROS signaling pathway. Redox Biol. 30:101411. doi:https://doi.org/10.1016/j.redox.2019.101411.
- Ma JY, Snook S, Garrovillo S, Johnson C, La D. 2017. An immunohistochemical investigation of renal phospholipidosis and toxicity in rats. Int J Toxicol. 36:386–394. doi:https://doi.org/10.1177/1091581817726040
- Ma Y, Ge A, Zhu W, Liu Y-N, Ji N-F, Zha W-J, Zhang J-X, Zeng X-N, Huang M. 2016. Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling. Oxid Med Cell Longev. 2016:1–13. doi:https://doi.org/10.1155/2016/5843672
- Matkovics B. 1988. Determination of enzyme activity in lipid peroxidation and glutathione pathways. Lab Diagn. 15:248–250.
- Mimić-Oka J, Simić T. 1997. Time course of renal glutathione levels in experimental Fanconi syndrome: an enzyme-based approach. Ren Fail. 19:373–381. doi:https://doi.org/10.3109/08860229709047723
- Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E. 2009. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol. 20:1754–1764. doi:https://doi.org/10.1681/ASN.2008111204.
- Moll UM, Wolff S, Speidel D, Deppert W. 2005. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol. 17:631–636. doi:https://doi.org/10.1016/j.ceb.2005.09.007
- Nissim I, Weinberg JM. 1996. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int. 49:684–695. doi:https://doi.org/10.1038/ki.1996.97
- Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS. 2006. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 355:1572–1582. doi:https://doi.org/10.1056/NEJMsa060185
- Özdemir S, Çomaklı S. 2018. Investigation of the interaction between bta-miR-222 and the estrogen receptor alpha gene in the bovine ovarium. Reprod Biol. 18:259–266. doi:https://doi.org/10.1016/j.repbio.2018.06.006
- Perumal N, Perumal M, Kannan A, Subramani K, Halagowder D, Sivasithamparam N. 2017. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells. Exp Cell Res. 355:124–141. doi:https://doi.org/10.1016/j.yexcr.2017.03.062
- Placer ZA, Cushman LL, Johnson BC. 1966. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem. 16:359–364. doi:https://doi.org/10.1016/0003-2697(66)90167-9
- Presnell JK, Schreibman MP, Humason GL. 1997. Humason’s animal tissue techniques. Johns Hopkins University Press: Baltimore, MD.
- Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. 2016. Oxidant mechanisms in renal injury and disease. Antiox Redox Sign. 25:119–146. doi:https://doi.org/10.1089/ars.2016.6665
- Ryan KM, Ernst MK, Rice NR, Vousden KH. 2000. Role of NF-κB in p53-mediated programmed cell death. Nature. 404:892–897. doi:https://doi.org/10.1038/35009130
- Sayed-Ahmed MM, Aleisa AM, Al-Rejaie SS, Al-Yahya AA, Al-Shabanah OA, Hafez MM, Nagi MN. 2010. Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling. Oxid Med Cell Longev. 3:254–261. doi:https://doi.org/10.4161/oxim.3.4.12714
- Sayed-Ahmed MM, Hafez MM, Aldelemy ML, Aleisa AM, Al-Rejaie SS, Al-Hosaini KA, Al-Harbi NO, Al-Harbi MM, Al-Shabanah OA. 2012. Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in ifosfamide-induced Fanconi syndrome rat model. Oxid Med Cell Longev. 2012:1–9. doi:https://doi.org/10.1155/2012/696704
- Sedlak J, Lindsay RH. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 25:192–205. doi:https://doi.org/10.1016/0003-2697(68)90092-4.
- Şehirli Ö, Şakarcan A, Velioğlu-Öğünç A, Çetinel Ş, Gedik N, Yeğen BÇ, Şener G. 2007. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats. Toxicol Appl Pharmacol. 222:33–41. doi:https://doi.org/10.1016/j.taap.2007.03.025
- Sener G, Sehirli Ö, Yegen BÇ, Cetinel S, Gedik N, Sakarcan A. 2004. Melatonin attenuates ifosfamide‐induced Fanconi syndrome in rats. J Pineal Res. 37:17–25. doi:https://doi.org/10.1111/j.1600-079X.2004.00131.x
- Sharifi-Rigi A, Heidarian E. 2019. Protective and anti-inflammatory effects of silymarin on paraquat-induced nephrotoxicity in rats. J Herb Med Pharmacol. 8:28–34. doi:https://doi.org/10.15171/jhp.2019.05
- Sionov RV, Haupt Y. 1999. The cellular response to p53: the decision between life and death. Oncogene. 18:6145–6157. doi:https://doi.org/10.1038/sj.onc.1203130
- Straka C, Hebart H, Adler-Reichel S, Werding N, Emmerich B, Einsele H. 2003. Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma. Oncology. 65:94–98. doi:https://doi.org/10.1159/000073368
- Sun Y, Oberley LW, Li Y. 1988. A simple method for clinical assay of superoxide dismutase. Clin Chem. 34:497–500. doi:https://doi.org/10.1093/clinchem/34.3.497
- Tian Y, Li Z, Shen B, Zhang Q, Feng H. 2017. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways. Int Immunopharmacol. 45:148–155. doi:https://doi.org/10.1016/j.intimp.2017.02.010
- Topal F, Nar M, Gocer H, Kalin P, Kocyigit UM, Gülçin İ, Alwasel SH. 2016. Antioxidant activity of taxifolin: an activity-structure relationship. J Enz Inhib Med Chem. 31:674–683. doi:https://doi.org/10.3109/14756366.2015.1057723
- Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH. 2003. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol. 14:1–10. doi:https://doi.org/10.1097/01.ASN.0000042803.28024.92
- Venkatesan R, Sadiq AM, Kumar JS, Lakshmi GR, Vidhya RJ. 2010. Effect of morin on mercury chloride induced nephrotoxicity. Ecoscan. 4:193–196.
- Wei Z, He X, Kou J, Wang J, Chen L, Yao M, Zhou E, Fu Y, Guo C, Yang Z. 2015. Renoprotective mechanisms of morin in cisplatin-induced kidney injury. Int Immunopharmacol. 28:500–506. doi:https://doi.org/10.1016/j.intimp.2015.07.009
- Woodland C, Ito S, Granvil CP, Wainer IW, Klein J, Koren G. 2000. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sci. 68:109–117. doi:https://doi.org/10.1002/jbt.22030
- Yang E, Korsmeyer SJ. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:386–401. doi:https://doi.org/10.1182/blood.V88.2.386.bloodjournal882386.
- Yazawa Y, Takagi T, Asakura S, Suzuki K, Kano Y. 1999. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines. J Orthop Sci. 4:231–237. doi:https://doi.org/10.3390/pathogens8010026
- Zeng L-H, Fung K-P, Wu T-W. 1994. Morin hydrate protects cultured rat glomerular mesangial cells against oxyradical damage. Life Sci. 55: L351–PL357. doi:https://doi.org/10.1007/s00204-011-0774-2